These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11861388)

  • 1. The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity.
    Azenshtein E; Luboshits G; Shina S; Neumark E; Shahbazian D; Weil M; Wigler N; Keydar I; Ben-Baruch A
    Cancer Res; 2002 Feb; 62(4):1093-102. PubMed ID: 11861388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma.
    Luboshits G; Shina S; Kaplan O; Engelberg S; Nass D; Lifshitz-Mercer B; Chaitchik S; Keydar I; Ben-Baruch A
    Cancer Res; 1999 Sep; 59(18):4681-7. PubMed ID: 10493525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions.
    Soria G; Yaal-Hahoshen N; Azenshtein E; Shina S; Leider-Trejo L; Ryvo L; Cohen-Hillel E; Shtabsky A; Ehrlich M; Meshel T; Keydar I; Ben-Baruch A
    Cytokine; 2008 Oct; 44(1):191-200. PubMed ID: 18790652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inflammatory chemokines CCL2 and CCL5 in breast cancer.
    Soria G; Ben-Baruch A
    Cancer Lett; 2008 Aug; 267(2):271-85. PubMed ID: 18439751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interplay between gastric cancer cell lines and PBMCs mediated by the CC chemokine RANTES plays an important role in tumor progression.
    Okita K; Furuhata T; Kimura Y; Kawakami M; Yamaguchi K; Tsuruma T; Zembutsu H; Hirata K
    J Exp Clin Cancer Res; 2005 Sep; 24(3):439-46. PubMed ID: 16270531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast carcinoma: a report on the potential usage of the CC chemokine RANTES as a marker for a progressive disease.
    Wigler N; Shina S; Kaplan O; Luboshits G; Chaitchik S; Keydar I; Ben-Baruch A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):940-3. PubMed ID: 12455185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CCL5 (RANTES) and CCR5 in prostate cancer.
    Vaday GG; Peehl DM; Kadam PA; Lawrence DM
    Prostate; 2006 Feb; 66(2):124-34. PubMed ID: 16161154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
    Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S
    Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions.
    Uría JA; Ståhle-Bäckdahl M; Seiki M; Fueyo A; López-Otín C
    Cancer Res; 1997 Nov; 57(21):4882-8. PubMed ID: 9354453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of neurotensin and NT1 receptor in human breast cancer: a potential role in tumor progression.
    Souazé F; Dupouy S; Viardot-Foucault V; Bruyneel E; Attoub S; Gespach C; Gompel A; Forgez P
    Cancer Res; 2006 Jun; 66(12):6243-9. PubMed ID: 16778199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: regulation of expression and potential mechanisms of antimalignant activity.
    Monti P; Leone BE; Marchesi F; Balzano G; Zerbi A; Scaltrini F; Pasquali C; Calori G; Pessi F; Sperti C; Di Carlo V; Allavena P; Piemonti L
    Cancer Res; 2003 Nov; 63(21):7451-61. PubMed ID: 14612545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines.
    Goldberg-Bittman L; Neumark E; Sagi-Assif O; Azenshtein E; Meshel T; Witz IP; Ben-Baruch A
    Immunol Lett; 2004 Mar; 92(1-2):171-8. PubMed ID: 15081542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase 26 proteolysis of the NH2-terminal domain of the estrogen receptor beta correlates with the survival of breast cancer patients.
    Savinov AY; Remacle AG; Golubkov VS; Krajewska M; Kennedy S; Duffy MJ; Rozanov DV; Krajewski S; Strongin AY
    Cancer Res; 2006 Mar; 66(5):2716-24. PubMed ID: 16510592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human detrusor smooth muscle cells release interleukin-6, interleukin-8, and RANTES in response to proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha.
    Bouchelouche K; Alvarez S; Horn T; Nordling J; Bouchelouche P
    Urology; 2006 Jan; 67(1):214-9. PubMed ID: 16413378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia/reoxygenation: a dynamic regulator of lysyl oxidase-facilitated breast cancer migration.
    Postovit LM; Abbott DE; Payne SL; Wheaton WW; Margaryan NV; Sullivan R; Jansen MK; Csiszar K; Hendrix MJ; Kirschmann DA
    J Cell Biochem; 2008 Apr; 103(5):1369-78. PubMed ID: 17685448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma.
    Romero JM; Aptsiauri N; Vazquez F; Cozar JM; Canton J; Cabrera T; Tallada M; Garrido F; Ruiz-Cabello F
    Tissue Antigens; 2006 Oct; 68(4):303-10. PubMed ID: 17026465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression.
    Pantschenko AG; Pushkar I; Anderson KH; Wang Y; Miller LJ; Kurtzman SH; Barrows G; Kreutzer DL
    Int J Oncol; 2003 Aug; 23(2):269-84. PubMed ID: 12851675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor cell specific expression of MMP-2 correlates with tumor vascularisation in breast cancer.
    Djonov V; Cresto N; Aebersold DM; Burri PH; Altermatt HJ; Hristic M; Berclaz G; Ziemiecki A; Andres AC
    Int J Oncol; 2002 Jul; 21(1):25-30. PubMed ID: 12063545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer.
    Niwa Y; Akamatsu H; Niwa H; Sumi H; Ozaki Y; Abe A
    Clin Cancer Res; 2001 Feb; 7(2):285-9. PubMed ID: 11234881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.